Alnylam Pharmaceuticals
ALNY
#622
Rank
A$51.28 B
Marketcap
$397.58
Share price
-1.16%
Change (1 day)
38.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company